Dr. Kavel H. Visrodia, MD

  • New York, NY
  • Gastroenterologist
NPI1376807206PAC ID2769628361
Medicare services, 2024
625
Medicare patients, 2024
288
Part D claims, 2024
96
Publications
72
MIPS score, 2024
100
Practice address
622 W 168th St, New York, NY 10032
Practice phone
Call (212) 297-4255
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Columbia University Irving Medical Center

New York, New York

See all 6 affiliations

Find Dr. Visrodia's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kavel H. Visrodia is a gastroenterologist in New York, New York

Dr. Visrodia practices at Columbia University Irving Medical Center in New York, New York.

Dr. Visrodia's NPI, 1376807206, was assigned on June 26, 2012. Dr. Visrodia graduated from Keck School of Medicine of USC in 2012. Dr. Visrodia holds New York license 292517.

NPI and contact details
Medicare PAC ID
2769628361
NPI enumeration date
June 26, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(212) 297-4255
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
40
Medical school graduation
2012

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kavel H. Visrodia practices at Columbia University Irving Medical Center in New York, New York

Dr. Visrodia's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

  • Columbia University Irving Medical Center
    622 W 168th St, New York, NY 10032 · New York CountyPhone(212) 297-4255

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Kavel H. Visrodia is affiliated with 4 sites of care and 2 medical groups

Dr. Visrodia's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Visrodia is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Visrodia to 2 more group practices and clinics and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Visrodia

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Kavel H. Visrodia's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Visrodia practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Columbia University Irving Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Visrodia practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kavel H. Visrodia is one of 1,583 gastroenterologists in New York

Gastroenterology is Dr. Visrodia's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Visrodia is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Visrodia's licenses on file in 4 states: New York, Massachusetts, Wisconsin and Minnesota.

Specialties and state licenses

  • Gastroenterology, New YorkPrimaryLicense 292517 · 2018 to 2026 · taxonomy 207RG0100X
  • Massachusetts license2019 to 2022
  • Wisconsin license2017 to 2019
  • Minnesota licenseLicense 56760 · 2013 to 2018

Clinical focus

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, colonoscopy, esophagus, stomach, or upper small intestine surgery, gastroenteritis, gastrointestinal bleeding, irritable bowel syndrome (IBS) and pancreas or bile duct endoscopy (ERCP) among the conditions Dr. Visrodia treats.

Gastroenterologists near Dr. Visrodia

Counts of gastroenterologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kavel H. Visrodia billed Medicare for 625 services in 2024

CMS data shows 625 Medicare services from Dr. Visrodia across 18 procedure codes in 2024, for 288 Medicare patients. Medicare paid $81,588 for them.

Medicare services, 2024625
Medicare patients288
Paid by Medicare$81,588
Procedure codes18

Dr. Visrodia's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2362024: 30228%
Surgery
2023: 2892024: 26110%
Imaging
2023: 502024: 6224%

Where Dr. Visrodia's Medicare services took place, 2024

  • In an office25941%
  • In a facility36659%

Dr. Visrodia compared with the New York median for gastroenterologists, 2024

  • Dr. Visrodia
  • New York median
Medicare services
625vs 42148% above
Medicare patients
288vs 23622% above
Part D claims
64vs 38283% below

Medians across 1,551 gastroenterologists in New York with Dmand AI profiles that report each measure.

Dr. Visrodia's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Visrodia

Need commercial claims for Dr. Visrodia?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Visrodia and other gastroenterologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kavel H. Visrodia treated 288 Medicare patients in 2024, average age 73

CMS counts 288 Medicare patients who saw Dr. Visrodia in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Visrodia's median patient age at 69, with 49% women.

Medicare patients, 2024288
Average age73
Average risk score2.23
Also on Medicaid26%

Dr. Visrodia's Medicare patients by age, 2024

Dr. Visrodia's Medicare patients by sex, 2024

  • Women14249%
  • Men14651%

Chronic conditions among Dr. Visrodia's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Diabetes49%
  4. Arthritis48%
  5. Ischemic heart disease36%
  6. Anxiety34%
  7. Chronic kidney disease33%
  8. Cancer27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Visrodia's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women49%
  • Men47%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kavel H. Visrodia wrote 96 Medicare Part D claims in 2024

In 2024, Dr. Visrodia wrote 96 Medicare Part D claims for 61 patients. 72% of them were for generic drugs. CMS names the drug for 64 of them, across 3 drugs with 11 or more claims each, at $886 in total drug cost. In 2019, CMS named 35 claims across 2 drugs.

Part D claims, 202496
Drugs named by CMS3
Total drug cost$886
Part D patients61

Dr. Visrodia's Part D claims by kind of drug, 2024

  • Generic69 claims72%
  • Brand-name and other27 claims28%

Dr. Visrodia's most prescribed drugs by claims, 2020

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Visrodia's Part D claims, 2024

  • Antibiotics15%14 of 96 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2019 to 2020

  • 2019
  • 2020
Claims for drugs CMS names
2019: 352020: 6483%

Drugs named by CMS: 3 in 2020, 2 in 2019.

See all prescribing by Dr. Visrodia

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kavel H. Visrodia scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Visrodia for performance year 2024, reported through an alternative payment model (APM). Dr. Visrodia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Visrodia as offering telehealth. CMS counts 208 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Visrodia, more than 91% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Visrodia's MIPS scores, performance year 2024

  • 100of 100Final score
  • 85.3of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Dr. Visrodia ranks in Medicare procedure volume

Upper gastrointestinal (GI) endoscopy for acid reflux
91st percentile208 procedures
Colonoscopy
54th percentile30 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find gastroenterologists like Dr. Visrodia by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kavel H. Visrodia has 72 publications on record

Dmand AI links 72 papers to Dr. Visrodia, published from 2013 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Esophageal Neoplasms, Barrett Esophagus and Endoscopic Mucosal Resection. Dr. Visrodia has published most often in Gastrointest Endosc. Dr. Visrodia's most frequent co-authors are Prasad Ganapathy Iyer, MD, Amrita Sethi, MD and Todd H. Baron, MD.

Papers72
Years published2013 to 2025

Dr. Visrodia's papers by year, 2016 to 2025

Topics Dr. Visrodia writes about most

  • Esophageal Neoplasms
  • Barrett Esophagus
  • Endoscopic Mucosal Resection
  • Adenocarcinoma
  • Equipment Contamination
  • Esophagus
  • Disinfection
  • Esophagoscopy

Dr. Visrodia's most frequent co-authors

Recent publications by Dr. Visrodia

See all 72 publications and co-authors

See who Dr. Visrodia researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Visrodia works with, so you can find a warm path to the right gastroenterologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kavel H. Visrodia received $86,788 in industry payments from 2016 to 2025

CMS Open Payments shows 135 general payments to Dr. Visrodia from 22 drug and device companies from 2016 to 2025. Grants make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $81,333.

General payments to Dr. Visrodia by program year, 2016 to 2025

General payments to Dr. Visrodia by kind, 2016 to 2025

$86.8Kin total
  • Grants$50,00058%
  • Speaker and faculty fees$20,25023%
  • Consulting fees$7,0008%
  • Food and beverage$5,7397%
  • Travel and lodging$3,7984%

Companies that paid Dr. Visrodia the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Visrodia

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kavel H. Visrodia graduated from Keck School of Medicine of USC

Dr. Visrodia graduated from Keck School of Medicine of USC in 2012.

  1. Medical schoolKeck School of Medicine of USC
  2. Board certified in gastroenterologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Kavel H. Visrodia accepts plans from 15 insurance carriers

Dr. Visrodia is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Elevance
  • Excellus BlueCross BlueShield
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Cigna
  • MVP Health Care
  • +7 more carriersWith a free account

Plan types Dr. Visrodia accepts, by number of carriers

  1. PPO9
  2. Medicare8
  3. HMO6
  4. EPO4
  5. Medicaid4
  6. POS4

Source: Dmand AI Insurance Network Data

Sources for Dr. Kavel H. Visrodia's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kavel H. Visrodia

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kavel H. Visrodia's NPI number?

Dr. Kavel H. Visrodia's NPI number is 1376807206. It was assigned on June 26, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. Kavel H. Visrodia?

Dr. Kavel H. Visrodia is a gastroenterologist in New York, New York. The primary specialty in the NPI Registry is Gastroenterology Physician (taxonomy code 207RG0100X).

Where does Dr. Kavel H. Visrodia practice?

Dr. Visrodia practices at 622 W 168th St, New York, NY 10032. Dr. Visrodia's primary practice is Columbia University Irving Medical Center in New York, New York. Dmand AI also links Dr. Visrodia to 2 group practices and clinics and 1 medical group.

What is Dr. Kavel H. Visrodia's office phone number?

The practice phone on file for Dr. Visrodia is (212) 297-4255.

What is Dr. Kavel H. Visrodia's medical license number?

Dr. Visrodia holds New York license 292517, one of the licenses on file in 4 states.

Which states has Dr. Kavel H. Visrodia been licensed in?

Dmand AI has state licenses on file for Dr. Visrodia in New York (2018 to 2026), Massachusetts (2019 to 2022), Wisconsin (2017 to 2019) and Minnesota (2013 to 2018).

Which hospitals is Dr. Kavel H. Visrodia affiliated with?

Dr. Visrodia is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.

What medical group is Dr. Kavel H. Visrodia part of?

Dr. Visrodia is linked to ColumbiaDoctors. Dmand AI links Dr. Visrodia to 1 more medical group.

Does Dr. Kavel H. Visrodia accept Medicare?

Yes. CMS data shows Dr. Visrodia billed Medicare for 625 services in 2024, and Dr. Visrodia accepts Medicare assignment.

Does Dr. Kavel H. Visrodia offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Visrodia as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Kavel H. Visrodia's MIPS score?

Dr. Visrodia's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Kavel H. Visrodia see?

CMS counts 288 Medicare patients who saw Dr. Visrodia in 2024, with an average age of 73.

Is Dr. Kavel H. Visrodia board certified?

Yes. Dr. Visrodia is board certified in gastroenterology by the American Board of Internal Medicine.

What services does Dr. Kavel H. Visrodia bill to Medicare?

In 2024, Dr. Visrodia's most billed Medicare services were office visit, established patient (99214), diagnostic imaging (74328) and office visit, new patient (99204).

Where did Dr. Kavel H. Visrodia go to medical school?

Dr. Visrodia graduated from Keck School of Medicine of USC in 2012.

What drugs does Dr. Kavel H. Visrodia prescribe most?

In 2020 Medicare Part D data, Dr. Visrodia's most prescribed drugs by claims were Gavilyte-G, Omeprazole and Ciprofloxacin HCl.

Has Dr. Kavel H. Visrodia received payments from drug or device companies?

CMS Open Payments shows $86,788 in general payments to Dr. Visrodia from 22 companies from 2016 to 2025. The largest total came from Boston Scientific Corporation.

How long has Dr. Kavel H. Visrodia been practicing?

Dr. Visrodia graduated from medical school in 2012, 14 years ago.

Does Dr. Kavel H. Visrodia do research?

Dmand AI links 72 publications to Dr. Visrodia, published from 2013 to 2025.

Who does Dr. Kavel H. Visrodia publish with?

Dr. Visrodia's most frequent co-authors are Prasad Ganapathy Iyer, MD (9 shared papers), Amrita Sethi, MD (8 shared papers) and Todd H. Baron, MD (5 shared papers).

What insurance does Dr. Kavel H. Visrodia accept?

Dr. Visrodia is in network with 15 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to gastroenterology practices?

See gastroenterologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)